Reversal of increased lymphocyte PC-1 activity in patients with Type 2 diabetes treated with metformin

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 6, 1999, Pages 400-404

  Stefanović, Vladisav ^a,b   Antić, Slobodan ^a   Mitić Zlatković, Marina ^a   Vlahović, Predrag ^a  

^a UNIVERSITY OF NI   (Serbia)

^b Inst of Nephrology and Hemodialysis   (Yugoslavia)

Author keywords

Aminopeptidase N; Dipeptidylpeptidase IV; Insulin resistance; Metformin; PC 1; Type 2 diabetes

Indexed keywords

CONCANAVALIN A; DIFFERENTIATION ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INSULIN RECEPTOR KINASE; METFORMIN; MICROSOMAL AMINOPEPTIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOTRANSFERASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LYMPHOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA CELL; PRIORITY JOURNAL;

ADULT; CELLS, CULTURED; CONCANAVALIN A; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; METFORMIN; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; STIMULATION, CHEMICAL; TETRADECANOYLPHORBOL ACETATE;

EID: 0033370073     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199911/12)15:6<400::AID-DMRR66>3.0.CO;2-4     Document Type: Article

References (25)

1. DeFronzo RA. The triumvirate: β-cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
2. Olofsky JM, Garvey WT, Henry RR, Brillon D, Matthaei S, Freidenberg GR. Cellular mechanisms of insulin resistance in Type II diabetes. Am J Med 1988; 85: 86-105.
3. Nolan JJ, Ludvik B, Baloga J, Reichart D, Olefsky JM. Mechanisms of the kinetic defect of insulin action in obesity and Type 2 diabetes. Diabetes 1997; 46: 994-1000.
4. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 1996; 39: 1190-1195.
5. Frittitta L, Youngren JF, Sbraccia P, et al. Increased aidpose tissue PC-1 content but not tumor necrosis factor-aplha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine kinase activity. Diabetologia 1997; 40: 282-289.
6. Youngren JF, Maddux BA, Sasson S, et al. Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport. Diabetes 1996; 45: 1324-1328.
7. Frittitta L, Spampinato D, Solini A, et al. Elevated PC-1 content in cultured skin fibroblasts with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic fractor in impaired insulin receptor signaling. Diabetes 1998; 47: 1095-1100.
8. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
9. Stumwoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in Type 2 diabetes. N Engl J Med 1995; 333: 550-554.
10. Fery F, Plat L, Balasse EO. Effects of metformin on the patways of glucose utilization after oral glucose in patients with Type 2 diabetes. Metabolism 1997; 46: 227-233.
11. Stith BJ, Goalstone ML, Espinoza R, Mossel C, Roberts D, Wiernsperger N. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in xenopus oocytes. Endocrinology 1996; 137: 2990-2999.
12. National Diabetes Data Group. Clasiffication and diagnosis of Diabetes Mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
13. Stefanović V, Golubović E, Vlahović P, Mitić-Zlatković M. Lymphocyte ectoenzymes in childhood idiopatic nephrotic syndrome. Pediatr Nephrol 1998; 12: 755-760.
14. Stefanović V, Vlahović P, Ardaillou R. Characterization and control of expression of cell surface alkaline phosphodiesterase I activity in rat mesangial glomerular cells. Ren Physiol Biochem 1995; 18: 12-20.
15. Stefanović V, Vlahović P, Ardaillou N, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular mesangial cells. Kidney Int 1992; 41: 1571-1580.
16. Stefanović V, Ardaillou N, Vlahović P, Placier S, Ronco P, Ardaillou R. Interferon-γ induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology 1993; 80: 465-470.
17. Godfine ID, Maddux BA, Youngren JF, Frittitta L, Trischitta V, Dohm GL. Membrane glycoptorein PC-1 and insulin resistance. Mol Cell Biochem 1998; 182: 177-184.
18. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart T. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 1995; 270: 22085-22088.
19. Rebbe NF, Tong BD, Hickman S. Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 1993; 30: 87-93.
20. Moe OA, Butler LG. The catalytic mechanism of bovine intestinal 5′-nucleotide phosphodiesterase. J Biol Chem 1983; 258: 6941-6946.
21. Hickman S, Wong-Yip YP, Rebbe NF, Greco JM. Formation of lipid-linked oligosaccharides by MOPC 315 plasmacytoma cells. Decreased synthesis by a non-secretory variant. J Biol Chem 1985; 260: 6098-6106.
22. Rebbe NF, Tong BD, Finley EM, Hickman S. Identification of nucleotide pyrophosphatase/alkaline phosphodiesterase I activity associated with the mouse plasma cell differentiation antigen PC-1. Proc Natl Acad Sci U S A 1991; 88: 5192-5196.
23. Schon E, Ansorge S. Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes. Biol Chem Hoppe Seyler 1990; 371: 699-705.
24. Pauly RP, Demuth H-U, Rosche F, et al. Inhibition of dipeptidyl peptidase IV (DP IV) in rat results in improved glucose tolerance (Abstract). Regul Pept 1996; 64: 148.
25. Balkan B, Kwasnik L, Miserendino R, Mone M, Hughes TE, Li H. Improved insulin secretion and oral glucose tolerance after in vivo inhibition of DPP-IV in obese Zucker rats (Abstract). Diabetologia 1997; 40 (Suppl. 1): A131.